Image

Pancreatic Cancer Diagnosis With FAPI-PET Imaging

Investigating Pancreatic Cancer with Investigational FAPI-PET Imaging

Recruiting
18-85 years
All
Phase 2/3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates pancreatic cancer. It focuses on using a new PET tracer called fibroblast activation protein inhibitor (FAPI) for imaging.

The study evaluates the effectiveness of 18F-FAPI-74 PET/CT in diagnosing pancreatic cancer, specifically looking at its ability to detect local lymph node and distant metastasis.

  • Who can participate: Adults aged 18 to 85 with suspected primary or recurrent pancreatic cancer can join. Participants must have a WHO performance score of 0-2 and be able to provide informed consent.
  • Study details: Participants will undergo PET/CT scans using the 18F-FAPI-74 tracer. The study will assess the tracer's ability to identify cancer spread.
  • Study timelines: The study will last from 2024 to 2026.
Print
Study details
    Positron Emission Tomography
    Pancreatic Cancer
    FAPI
    Diagnostics
    Recurrent Pancreatic Cancer
    Oncologic Surgery
    Imaging
    Diagnostic
    Staging

NCT07098598

Turku University Hospital

30 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.